Dr. Gurinder Kaur, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,939 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $671.88 | 35 | $0 (2024) |
| PFIZER INC. | $414.16 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $285.57 | 14 | $0 (2024) |
| ABBVIE INC. | $193.21 | 8 | $0 (2024) |
| Inari Medical, Inc. | $165.82 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.71 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $45.52 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $28.80 | 2 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $24.66 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.55 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $875.90 | 35 | Janssen Pharmaceuticals, Inc ($197.17) |
| 2023 | $420.42 | 16 | Janssen Pharmaceuticals, Inc ($195.83) |
| 2022 | $325.29 | 21 | Janssen Pharmaceuticals, Inc ($174.11) |
| 2021 | $138.51 | 9 | Janssen Pharmaceuticals, Inc ($87.07) |
| 2020 | $65.97 | 4 | Philips Electronics North America Corporation ($18.02) |
| 2019 | $44.33 | 3 | Allergan Inc. ($17.36) |
| 2018 | $68.84 | 6 | PFIZER INC. ($68.84) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/18/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 18 | $3,843 | $1,457 |
| 2022 | 5 | 242 | 294 | $113,510 | $26,396 |
| 2021 | 6 | 122 | 150 | $49,205 | $12,527 |
| 2020 | 6 | 265 | 357 | $70,330 | $23,617 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 18 | $3,843 | $1,457 | 37.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 103 | 123 | $71,487 | $15,537 | 21.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 61 | 71 | $21,978 | $4,299 | 19.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 55 | $11,000 | $2,975 | 27.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 22 | 24 | $4,320 | $1,936 | 44.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 21 | $4,725 | $1,649 | 34.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 31 | 33 | $17,394 | $4,286 | 24.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 22 | 41 | $11,838 | $2,909 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 26 | $5,200 | $1,487 | 28.6% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 13 | 13 | $5,187 | $1,313 | 25.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 20 | 21 | $6,706 | $1,287 | 19.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 16 | 16 | $2,880 | $1,244 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 94 | 173 | $34,600 | $8,764 | 25.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 65 | 65 | $11,700 | $4,850 | 41.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 32 | 32 | $10,400 | $4,676 | 45.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 27 | 27 | $6,075 | $2,800 | 46.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 19 | $4,275 | $1,392 | 32.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 35 | 41 | $3,280 | $1,136 | 34.6% |
About Dr. Gurinder Kaur, MD
Dr. Gurinder Kaur, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1760895759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gurinder Kaur, MD has received a total of $1,939 in payments from pharmaceutical and medical device companies, with $875.90 received in 2024. These payments were reported across 94 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,939).
As a Medicare-enrolled provider, Kaur has provided services to 642 Medicare beneficiaries, totaling 819 services with total Medicare billing of $63,997. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Syracuse, NY
- Active Since 06/06/2014
- Last Updated 02/07/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1760895759
Products in Payments
- XARELTO (Drug) $671.88
- ELIQUIS (Drug) $448.16
- ENTRESTO (Drug) $285.57
- FLOWTRIEVER CATHETER, S (Device) $165.82
- TEFLARO (Drug) $149.42
- JARDIANCE (Drug) $53.71
- AVYCAZ (Drug) $38.09
- Stivarga (Drug) $24.66
- DALVANCE (Drug) $23.06
- LifeVest (Device) $20.55
- (8874) inCourage (Device) $18.02
- CHANTIX (Drug) $11.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syracuse
Seokhyun Jin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,625
Dr. Avneet Singh, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $16,015
Dr. Rebecca Jameson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,760
Nelson Sofoluke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,288
Dr. Tarek Ibrahim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,187
Dr. David Padalino, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,144